Effects of EpCAM overexpression on human breast cancer cell lines

BACKGROUND: Recently, EpCAM has attracted major interest as a target for antibody- and vaccine-based cancer immunotherapies. In breast cancer, the EpCAM antigen is overexpressed in 30-40% of all cases and this increased expression correlates with poor prognosis. The use of EpCAM-specific monoclonal...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Gostner, Johanna M, Fong, Dominic, Wrulich, Oliver A, Lehne, Florian, Zitt, Marion, Hermann, Martin, Krobitsch, Sylvia, Martowicz, Agnieszka, Gastl, Guenther, Spizzo, Gilbert
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2011
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3042418/
https://ncbi.nlm.nih.gov/pubmed/21281469
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-11-45
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados